Focusing on these areas can help healthcare organizations reduce the incidence of denials, optimize revenue cycle performance and enhance overall patient satisfaction.
The combination of technology and cross-functional collaboration allows providers to address denials and achieve optimal revenue performance.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The new era of full-stack compute-enabled bio companies will drive incredible advances in human health.
Despite artificial intelligence’s growing role in drug research, a fully AI-generated molecule has yet to advance from discovery all the way through clinical development. A novel molecule may eventually meet that goal, but some industry observers say it’s too early to focus on winning a race that has many twists and turns yet to come.
Don’t bet so big on AI solutions with “someday potential” that you ignore tools that can solve challenges and generate ROI now. Here are five critical AI investments that provide “right now” value for health systems, clinicians and patients.
Biopharma companies are harnessing AI tools for multiple aspects of drug development such as identifying drug development targets, modeling a drug's effect on the body, and more.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Many experts think technology will help mitigate healthcare's burnout crisis and workforce shortage, but the healthcare industry still has a lot to figure out when it comes to choosing which tools to deploy and getting its workers on board with these new tools, according to a new report from GE HealthCare.
Invite-only, in-person event series for industry leaders like you. Join us to uncover product and ML innovation with our guests and speakers.
No matter how much data the AI has on you, missing is the personal relationship. Emerging tech, wearables—all that is great. But at the end of the day, so much of it still depends on interpersonal relationship building and leveraging, adding an intelligence layer to the loop.
Model building is now simplified more than ever because of automation and tool intelligence achieved in model building. With a surplus of MLOps tools, users of all sizes and backgrounds are now focusing on model manufacturing. But the question remains - are all models usable?
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Machine learning algorithms have reached a familiar milestone in the healthcare industry --in order for them to be more widely embraced by providers, different approaches to roadtesting and validating them are underway.
GSK is making greater use of artificial intelligence and computational techniques as part of its drug discovery efforts. Speaking during the HLTH conference in Las Vegas, executive Mike Montello likened his company's techniques to the efforts to study and analyze images from outer space.
Alviss.ai CEO and Founder Dr. Pavel Overtchouk talks about how the company’s stroke prediction software seeks to be the first attempt to apply predictive medicine to cardiovascular interventions and heart surgery.
Mount Sinai researchers published a study that could improve neuroscientists’ understanding of the progression of Alzheimer’s and other forms of cognitive decline. It proved that white matter may be a more important region to look at than was previously thought.
As part of its Envision U.S. Healthcare Summit, Microsoft conducted interviews with executives at Aetna CVS Health and Humana to highlight some of the ways these companies are adapting to consumerization of healthcare.